All In MedTech

Device Trial Radar · NCT06049654

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

Clinical Trial of the Results of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

Last checked: Nov 20, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 104 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

104

Planned (sponsor's estimate)

Start

Feb 1, 2024

Primary completion

Nov 1, 2027

Study completion Nov 1, 2027

Sponsor

Lead sponsor
Fundación EPICAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 22, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The VIVALL-2 study is a randomized trial to compare the self-expandable supra-annular Allegra and the balloon-expandable intra-annular Edwards transcatheter valve systems in patients with degenerated biological aortic surgical valve.

Conditions

  • Aortic Valve Stenosis
  • Structural Valve Deterioration

Interventions

  • NVT ALLEGRA TAVI System TFDevice

    Transcatheter aortic valve implantation of a NVT ALLEGRA TAVI System TF in patients with severe haemodynamical valve deterioration of a biological aortic valve implanted surgically

  • EDWARDS SAPIEN 3 or SAPIEN ULTRA SYSTEMDevice

    Transcatheter aortic valve implantation of an EDWARDS SAPIEN 3 SYSTEM in patients with severe haemodynamical valve deterioration of a biological aortic valve implanted surgically

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Trans-aortic mean gradient after Valve-in-Valve procedure, measured by transthoracic echocardiography (TTE).Time frame: 30 days

Locations

12 sites in 3 countries. Site status is shown where the registry gives one.

  • Azienda Ospedaliero- Universitaria di Alessandria

    Alessandria, Italy · Recruiting

  • ASST Spedali Civili di Brescia

    Brescia, Italy · Recruiting

  • Azienda Ospedaliera di Perugia

    Perugia, Italy · Recruiting

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.